2nd Quarter - Report
VENN STRATEGIES for REGENERON PHARMACEUTICALS, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Firm
Income
$120,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 20, 2016 | $120,000 | Replaced |
| 2nd Quarter - Amendment | Jul 24, 2017 | $100,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General issues relating to the bio-pharmaceutical sector, innovation, and health care manufacturing
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIM CAREY | Legislative Director for U.S. Representative Brad Sherman (D-CA), Deputy Legislative Director for Representative Anna G. Eshoo (D-CA) |
| NATASCHA CUMBERLIDGE | Rep. John Tierney (D-MA), where she most recently served as the Congressman's Senior Legislative Assistant |
| ELIZABETH LEE | Senior Policy Advisor to the Administrator of the Health Resources and Services Administration, legislative aide to Senator Tammy Baldwin |
| DREW LITTMAN | Chief of Staff to Senator Al Franken (D-MN) |
| STEPHANIE SILVERMAN | — |
| ERICA WHITE | press office of Senator Chuck Schumer (D-NY) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.